Leidos director receives stock and option awards

Leidos Holdings, Inc. director Noel B. Geer reported new equity compensation awards.

Rhea-AI Filing Summary

Leidos Holdings, Inc. director Noel B. Geer reported new equity compensation awards. On 2026-05-08, Geer received a grant of 1,067 shares of Common Stock, bringing his directly held common stock to 44,273.8435 shares.

He was also granted stock options for 1,281 shares of Common Stock at an exercise price of $131.2600 per share, which vest in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholders’ meeting. In addition, indirect holdings include 32,000 shares held by a family trust and 2,000 shares held by his spouse.

Insider Trade Summary

Grant/Award: 2,348 shares

Grant/Award 4 txns

Insider Geer Noel B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	1,281	$0.00	$0.00
Grant/Award	Common Stock	1,067	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 1,281 contracts (Direct); Common Stock — 44,273.8435 shares (Direct); Common Stock — 2,000 shares (Indirect, By Spouse); Common Stock — 32,000 shares (Indirect, by Family Trust)

Footnotes (1)

1. F1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.

Key Figures

Stock grant: 1,067 shares Direct holdings after grant: 44,273.8435 shares Stock option grant: 1,281 options +3 more

6 metrics

Stock grant 1,067 shares Common Stock awarded on May 8, 2026

Direct holdings after grant 44,273.8435 shares Common Stock directly owned after transactions

Stock option grant 1,281 options Rights to buy Common Stock granted May 8, 2026

Option exercise price $131.2600 per share Exercise price for 1,281 stock options

Family trust holdings 32,000 shares Leidos Common Stock held by Family Trust

Spouse holdings 2,000 shares Leidos Common Stock held by spouse

Key Terms

Stock Option (Right to Buy), Grant, award, or other acquisition, Family Trust, indirect, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Family Trust financial

"nature_of_ownership: "by Family Trust""

indirect financial

"ownership_type: "indirect""

exercise price financial

"conversion_or_exercise_price: "131.2600""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Noel B. Geer report in the latest Leidos (LDOS) Form 4?

Noel B. Geer reported a grant of 1,067 shares of Leidos common stock and stock options for 1,281 shares. These awards represent compensation, not open‑market purchases or sales, and increase his direct and derivative exposure to Leidos shares.

What is the exercise price and vesting schedule of Noel B. Geer’s new Leidos (LDOS) stock options?

The new stock options have an exercise price of $131.2600 per share for 1,281 underlying shares. They vest in full on the earlier of the first anniversary of the grant date or when the next annual meeting of Leidos stockholders concludes.

How many Leidos (LDOS) common shares does Noel B. Geer hold directly after this Form 4?

After the reported grant, Noel B. Geer directly holds 44,273.8435 shares of Leidos common stock. This figure reflects his direct ownership position following the award of 1,067 additional shares as part of his compensation package.

What indirect Leidos (LDOS) holdings related to Noel B. Geer are disclosed in the Form 4?

The filing lists 32,000 Leidos common shares held indirectly by a family trust and 2,000 shares held by his spouse. These positions are reported as indirect ownership interests associated with Noel B. Geer.

Does the Noel B. Geer Form 4 for Leidos (LDOS) show any stock sales or open‑market purchases?

The Form 4 shows no open‑market purchases or sales. Reported transactions are grants or awards of common stock and stock options, coded as acquisitions, rather than discretionary buying or selling in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 08:57 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Geer Noel B

(Last) (First) (Middle)

1750 PRESIDENTS STREET

(Street)

RESTON VIRGINIA 20190

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/08/2026		A		1,067	A	$0	44,273.8435	D
Common Stock								2,000	I	By Spouse
Common Stock								32,000	I	by Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$131.26	05/08/2026		A		1,281		05/08/2027(1)	05/07/2033	Common Stock	1,281	$0	1,281	D

Explanation of Responses:

1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.

Remarks:

	/s/ Ramune M. Kligys by PoA of Noel B. Geer	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)